Retinoic Acid Derivatives: Difference between revisions
Jump to navigation
Jump to search
(→Guidance: updated to be more permissive) |
|||
| Line 14: | Line 14: | ||
==Guidance== | ==Guidance== | ||
Generally unacceptable if ever taken Etretinate (Tigason) | Generally unacceptable if ever taken Etretinate (Tigason). | ||
At | Acceptable: | ||
Donors having taken, or currently taking, acitretin (Neotigason) or Isotretinoin (Roaccutane) may join the register. | |||
*At VT/Work up, must inform transplant centre if a donor is taking any of these medications, or has done so at any point in the last 12 months. | |||
==Pseudonyms or Related Conditions== | ==Pseudonyms or Related Conditions== | ||
Latest revision as of 15:34, 4 September 2025
Acceptability at Recruitment
QUALIFIED
Acceptability at CT / Work-Up
QUALIFIED
Individual at Risk
Recipient
Explanation of Condition
A group of drugs used to treat a number of inflammatory conditions, such as acne or psoriasis.
However, they can cause severe congenital defects if given to pregnant women.
Guidance
Generally unacceptable if ever taken Etretinate (Tigason).
Acceptable: Donors having taken, or currently taking, acitretin (Neotigason) or Isotretinoin (Roaccutane) may join the register.
- At VT/Work up, must inform transplant centre if a donor is taking any of these medications, or has done so at any point in the last 12 months.
Pseudonyms or Related Conditions
Version
Version 1, Edition 1
Date of Last Update
15th June 2012